The Department of Pharmaceuticals has prepared the Uniform Code of Pharmaceuticals Marketing Practices (UCPMP) and its voluntarily adoption and compilation was started from January 1 this year.
The code also prohibits companies from supplying drugs as samples, which are used to treat depression, inducing sleep such as hypnotic, sedative or tranquilliser.
Also Read
"As of now it is voluntary for pharmaceuticals companies to follow UCPMP, but we are considering to make it compulsory in next few months," a senior government official told PTI.
A process has already been started to rework the entire code so that it could be make compulsory and the department will hold discussions for the same with all stakeholders including industry, Medical Council of India and others, the official added.
Discussions will also take place with Drug Controller General of India, Health Ministry and NGOs, the official said.
The marketing code which also cover medical devices sector was initially implemented from January 1 this year for a period of six months, which was extended for two months till August 31 and now has been extended for four months till December 31 this year.
As per the code, the companies can extend funding for medical research and study through approved institutions as per law and it should be fully disclosed.
The code also have stringent measures for audio video promotional activities and for the supply of free samples of medicines.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)